Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
China · Delayed Price · Currency is CNY 83.37
+5.56 (7.15%)
Oct 28, 2026, 3:00 PM CST
SHA:688131 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,214 | 2,877 | 2,270 | 1,880 | 1,358 | 969.23 |
Revenue Growth | 27.26% | 26.73% | 20.75% | 38.44% | 40.12% | 52.61% |
Gross Profit Gross Profit Growth | 1,408 | 1,234 | 959.67 | 766.71 | 655.85 | 495.49 |
Operating Income Operating Income Growth | 411.81 | 363.55 | 263.41 | 148.61 | 158.74 | 201.78 |
Net Income Net Income Growth | 259.25 | 239.81 | 201.59 | 127.45 | 193.64 | 190.98 |
Earnings Per Share EPS Growth | 1.22 | 1.13 | 0.96 | 0.61 | 0.95 | 1.07 |
EPS Growth | -10.02% | 17.71% | 57.38% | -35.79% | -11.33% | 27.82% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Molecular Building Blocks, Tool Compounds and Biochemical Reagents Molecular Building Blocks, Tool Compounds and Biochemical Reagents Growth | 1,991 |
Active Pharmaceutical Ingredient, Intermediate and Preparations Active Pharmaceutical Ingredient, Intermediate and Preparations Growth | 872.24 |
Total Total Growth | 2,863 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,619 | 1,551 | 1,329 | 483.61 | 477.36 | 1,037 |
Total Debt Total Debt Growth | 2,400 | 2,242 | 1,940 | 1,028 | 645.95 | 196.66 |
Net Cash (Debt) Net Cash Growth | -781.67 | -690.43 | -611.3 | -544.2 | -168.59 | 840.52 |
Net Cash Growth | - | - | - | - | - | 290.72% |
Net Cash Per Share Net Cash Per Share Growth | -3.68 | -3.25 | -2.91 | -2.60 | -0.83 | 4.72 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 405.24 | 317.75 | 381.96 | -63.61 | -240.23 | 57.83 |
Capital Expenditures CapEx Growth | -208.15 | -221.79 | -304.46 | -259.77 | -581.36 | -287.69 |
Free Cash Flow Free Cash Flow Growth | 197.1 | 95.96 | 77.5 | -323.37 | -821.59 | -229.85 |
Free Cash Flow Growth | 165.16% | 23.83% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 43.82% | 42.90% | 42.27% | 40.78% | 48.29% | 51.12% |
Operating Margin | 12.81% | 12.64% | 11.60% | 7.90% | 11.69% | 20.82% |
Pretax Margin | 8.92% | 9.59% | 10.50% | 6.82% | 14.62% | 21.62% |
Profit Margin | 8.07% | 8.34% | 8.88% | 6.78% | 14.26% | 19.70% |
FCF Margin | 6.13% | 3.34% | 3.41% | -17.20% | -60.50% | -23.71% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.240 | 0.230 | 0.190 | 0.107 | 0.194 | 0.193 |
Dividend Per Share Growth | 4.35% | 21.05% | 77.40% | -44.77% | 0.41% | - |
Dividend Yield | 0.29% | 0.32% | 0.53% | 0.29% | 0.35% | 0.21% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 68.34 | 63.75 | 37.35 | 61.43 | 59.62 | 96.80 |
Forward PE | 51.04 | 43.42 | 32.85 | 21.99 | 32.59 | 70.32 |
P/FCF Ratio | 90.20 | 159.31 | 97.17 | - | - | - |
PS Ratio | 5.53 | 5.31 | 3.32 | 4.16 | 8.50 | 19.07 |